Inventor
KUANG RONGZE
US25 patents
⚠️ This page may combine multiple inventors who share the name “KUANG RONGZE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
13 patentsUS10472347B2Nov 12, 2019
Aminopyrazine compounds with A2A antagonist properties
MERCK SHARP & DOHME5 citations72
US10011585B2Jul 3, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations72
US9868727B2Jan 16, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME3 citations72
US9783530B2Oct 10, 2017
Factor Xla inhibitors
MERCK SHARP & DOHME2 citations72
US10822338B2Nov 3, 2020
Substituted aminoquinazoline compounds as A2A antagonist
MERCK SHARP & DOHME2 citations71
US10011615B2Jul 3, 2018
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
MERCK SHARP & DOHME3 citations71
US10138212B2Nov 27, 2018
Aminoquinazoline compounds as A2A antagonist
MERCK SHARP & DOHME2 citations70
US10081617B2Sep 25, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations70
US9676780B2Jun 13, 2017
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
MERCK SHARP & DOHME2 citations61
US8569312B2Oct 29, 2013
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51
US8476274B2Jul 2, 2013
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51
US11046714B2Jun 29, 2021
2,2-difluorodioxolo A2A receptor antagonists
MERCK SHARP & DOHME0 citations48
US10143681B2Dec 4, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME0 citations41
MERCK SHARP & DOHME LLC
6 patentsUS12304899B2May 20, 2025
Factor XI activation inhibitors
MERCK SHARP & DOHME LLC0 citations49
US12466831B2Nov 11, 2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
MERCK SHARP & DOHME LLC0 citations48
US12428397B2Sep 30, 2025
Factor XI activation inhibitors
MERCK SHARP & DOHME LLC0 citations48
US12414952B2Sep 16, 2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
MERCK SHARP & DOHME LLC0 citations48
US12528786B2Jan 20, 2026
Plasma kallikrein inhibitors
MERCK SHARP & DOHME LLC0 citations45
US12459927B2Nov 4, 2025
Plasma kallikrein inhibitors
MERCK SHARP & DOHME LLC0 citations44
SCHERING CORP
2 patentsUS7511062B2Mar 31, 2009
Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
SCHERING CORP31 citations90
US7956189B2Jun 7, 2011
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore
SCHERING CORP7 citations80